1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical characteristics of patients (n = 78)a
Clinical Characteristic Age (yr) 67 ± 9 Male sex 57 (73%) Classification event TIA 30 (38%) Stroke 41 (53%) Amaurosis fugax 7 (9%) Hypercholesterolemia 43 (55%) Hypertension 56 (72%) Diabetes mellitus 19 (24%) Current smoking No 58 (74%) Yes 20 (26%) Body mass index 25.2 (24.3–28.4) Current use Antiplatelet therapy 36 (46%) Oral anticoagulants 0 (0%) Statins 36 (46%) Antihypertensive medication 50 (64%) Antidiabetic medication 13 (17%) History Ischemic stroke or TIA 13 (17%) Ischemic heart disease 16 (21%) Peripheral arterial disease 15 (19%)
↵a Data are mean ± SD, absolute numbers of patients (%), or median (25th–75th percentile).